Calvin Meaney

nephrology pharmacist & academic at @UBPharm
dad, husband, woodworking & cooking enthusiast
tweets are my own

[Calvin Meaney @DrMeaney]

@deepaRD @kidneymedmgmt https://t.co/K7REK5KGao

[AKHOMM @kidneymedmgmt]

Struggling to manage pain in patients with CKD? This course equips clinicians with tools to address pain holistically. Learn about pain types, safe medication use, and create personalized treatment plans.

Sign up now: https://t.co/85MDpuCAXH

#CKDcare #PainManagement

[AKHOMM @kidneymedmgmt]

It's time to transition from Cockcroft-Gault to eGFR for medication-related decisions!

https://t.co/7d4O61GFEj

[Wendy St. Peter @WendyStPeter002]

Should you use eGFR or Cockcroft-Gault eCrCL for medication dosing? See what our NKF Workgroup has to say. @UMN_Pharmacy @ACPEpharmacy @BPSweb @GTMRxInstitute @pharmacists @kidneymedmgmt @RPANephrology @ASNKidney @ANNAnurses @futurefamilymed @AmDiabetesAssn @kidneymedmgmt

[AKHOMM @kidneymedmgmt]

Managing anxiety and depression in chronic kidney disease presents unique challenges. Explore tailored treatment options and learn how to develop effective, patient-centered care plans in this CE module!

🔗 Enroll at https://t.co/nPZtvwJZqr

[AKHOMM @kidneymedmgmt]

Heading to ACCP? Don’t miss Drs. Josh Neumiller and Wendy St. Peter's presentation, 'A Systematic Review of Coordinated Care in CKM Conditions' on Saturday, Oct 12 from 11:30 AM to 1:00 PM. Learn about the critical role pharmacists play in coordinated kidney care.

[AKHOMM @kidneymedmgmt]

With kidney function decline in CKD, dosage adjustments are crucial to minimize toxicity & ensure medication efficacy. We’re excited to announce our newest module which explores pharmacokinetic changes in CKD & provides practical medication examples.
https://t.co/KaEuwpzUwi

[ACCP @ACCP]

Congratulations to ACCP member Gina M. Prescott and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: https://t.co/llh4stPQqj

@JACCPJournal #MakingAnImpact #ACCP #TwitteRx

[ACCP @ACCP]

Congratulations to ACCP member Collin M. Clark and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: https://t.co/rKYMLNUcPH

@JACCPJournal #MakingAnImpact #TwitteRx #ACCP

[AKHOMM @kidneymedmgmt]

Did you know that a lab value of 5.1 indicates the onset of high potassium? That's why on May 1, we observe High Potassium Awareness Day, raising awareness about the condition & its management. For insights into managing hyperkalemia, explore our module at https://t.co/Dx2ouqPtip

[AKHOMM @kidneymedmgmt]

Are you interested in advancing pharmacy services in your clinic? Check out our currently enrolling Learning and Action Collaborative, designed to empower clinics like yours with the latest strategies, insights, and best practices in pharmaceutical care.
https://t.co/jbh3mNz9aA

[Calvin Meaney @DrMeaney]

@NephroSeeker @Ask_Renal Phenytoin to induce metabolism worked for us https://t.co/Oap7mlhvAS

[Pharmacotherapy @PharmacoJournal]

This study compared urinary biomarkers neutrophil gelatinase-associated lipocalin with kidney injury molecule-1 in critically ill children exposed to vancomycin who did and did not develop AKI as defined by changes in SCr. https://t.co/cNwJKmhBzL @NFuscoPharmD @accpnephrprn

[AKHOMM @kidneymedmgmt]

Join us in our FREE CE exploring groundbreaking STRATEGIES for advancing care in Black individuals with CKD. From building diverse teams to enhancing medication management, let's empower change in healthcare! 💪 #CKD #HealthEquity #PharmacyEducation" https://t.co/G5yOq7dBFn

[AKHOMM @kidneymedmgmt]

Learn about STRATEGIES to improve pharmacoequity, overcome BARRIERS to access medications and utilize tools to improve medication use in Black persons with CKD.
🔗 FREE AKHOMM CE module: https://t.co/G5yOq7dBFn

#CKD #pharmacoequity

[AKHOMM @kidneymedmgmt]

What are the different MRAs that are commercially available? And what evidence supports their use in patients with kidney disease?

🔗 Learn more at: https://t.co/aBqo42xhRt

#KidneyDisease #TwitteRX #NephTwitter

[AKHOMM @kidneymedmgmt]

Hyperkalemia is a significant risk of medications that slow progression of chronic kidney disease. Unfortunately, evidence-based guidelines for managing it is sparse.

To learn more about risks, prevention, & treatment, enroll here: https://t.co/ZdArodnaiB

#TwitteRX

[Calvin Meaney @DrMeaney]

Honored to have authored the hyperkalemia module, check it out now!

[AKHOMM @kidneymedmgmt]

We are excited to share that we have added five new modules to our curriculum!

Register today at: https://t.co/V8xo4JnHWx

[AKHOMM @kidneymedmgmt]

Looking to learn how to slow chronic kidney disease progression? Here’s how in four simple steps.

#TwitteRX #pharmacists #AKHOMM #NephTwitter #kidneycare #nephrology #healthcareprofessionals #internalmedicine #primarycare

[Calvin Meaney @DrMeaney]

Teams including pharmacists are highly encouraged to submit proposals!
#TwitteRx
#AKHOMM
#pharmacy

[NKF Nephrology Professionals @NKF_NephPros]

Teamwork makes the dream work! 📢 Kidney Team in Action proposals are now open. Accepted proposals will be invited to speak at the 2024 #NKFClinicals in CA 🌞🌴 Click for more info & to submit how your team's collaboration is positively impacting outcomes. https://t.co/KVwMxvWg6d